BsUFA Suggestions From Sponsors Sound Easy, But Changes May Be Difficult For US FDA

 
• By Derrick Gingery
  
Woman holding elephant
With no assessment team focused solely on biosimilars, best practices for the applications must be implemented throughout OND. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics